Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.9B | 2.0B | 1.9B | 2.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 774M | 720M | 727M | 740M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 468M | 508M | 470M | 480M |
| Tax provision | 95M | 107M | 88M | 88M |
| Net income | 373M | 401M | 382M | 392M |
| Basic EPS | 0.8 | 0.8 | 0.8 | 0.8 |
| Diluted EPS | 0.8 | 0.8 | 0.8 | 0.8 |
| Basic average shares | 22.6M | 22.7M | 23.0M | 23.4M |
| Diluted average shares | 22.8M | 22.9M | 23.1M | 23.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 373M | 401M | 382M | 392M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |